Key Financial Data Of Reporting Company

Modalis Therapeutics Corporation - Filing #7581546

Concept 2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-06-30
2021-01-01 to
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-780,483,000 JPY
-1,231,299,000 JPY
-464,982,000 JPY
Net assets
4,812,663,000 JPY
5,549,212,000 JPY
6,286,408,000 JPY
Total assets
5,343,143,000 JPY
6,069,137,000 JPY
6,697,362,000 JPY
Basic earnings (loss) per share
-26.70
-11.58
-25.70
0.62
-6.41
Diluted earnings per share
0.59
Equity-to-asset ratio
0.900 xbrli:pure
0.914 xbrli:pure
0.939 xbrli:pure
Net cash provided by (used in) operating activities
-713,384,000 JPY
-747,466,000 JPY
18,377,000 JPY
Net cash provided by (used in) investing activities
-118,965,000 JPY
171,563,000 JPY
275,022,000 JPY
Net cash provided by (used in) financing activities
3,653,000 JPY
72,633,000 JPY
56,436,000 JPY
Cash and cash equivalents
4,158,491,000 JPY
4,936,193,000 JPY
5,784,579,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.